|
GB0500492D0
(en)
|
2005-01-11 |
2005-02-16 |
Cyclacel Ltd |
Compound
|
|
US20060281768A1
(en)
|
2005-06-10 |
2006-12-14 |
Gaul Michael D |
Thienopyrimidine and thienopyridine kinase modulators
|
|
KR20090087094A
(ko)
|
2006-11-28 |
2009-08-14 |
노파르티스 아게 |
Iap 억제제 및 flt3 억제제의 조합물
|
|
JPWO2008111441A1
(ja)
|
2007-03-05 |
2010-06-24 |
協和発酵キリン株式会社 |
医薬組成物
|
|
CA2702126A1
(en)
|
2007-10-24 |
2009-04-30 |
Merck Sharp & Dohme Corp. |
Heterocycle amide t-type calcium channel antagonists
|
|
FR2926553B1
(fr)
|
2008-01-23 |
2010-02-19 |
Sanofi Aventis |
Derives d'indole-2-carboxamides et d'azaindole-2- carboxamides substitues par un groupe silanyle, leur preparation et leur application en therapeutique
|
|
WO2010042337A1
(en)
|
2008-10-07 |
2010-04-15 |
Merck Sharp & Dohme Corp. |
Novel 6-azaindole aminopyrimidine derivatives having nik inhibitory activity
|
|
CN101723936B
(zh)
|
2008-10-27 |
2014-01-15 |
上海睿星基因技术有限公司 |
激酶抑制剂及其在药学中的用途
|
|
TW201022262A
(en)
|
2008-10-29 |
2010-06-16 |
Astrazeneca Ab |
Novel compounds 515
|
|
CN102438588B
(zh)
|
2009-03-23 |
2015-04-01 |
埃姆比特生物科学公司 |
使用联合治疗法治疗疾病的方法
|
|
US8435980B2
(en)
|
2009-07-15 |
2013-05-07 |
Abbvie Inc. |
Pyrrolopyridine inhibitors of kinases
|
|
ES2622138T3
(es)
|
2010-06-23 |
2017-07-05 |
Hanmi Science Co., Ltd. |
Nuevos derivados de pirimidina condensados para la inhibición de la actividad tirosina quinasa
|
|
UY33539A
(es)
|
2010-08-02 |
2012-02-29 |
Astrazeneca Ab |
Compuestos químicos alk
|
|
DK3686193T3
(da)
|
2011-07-27 |
2022-05-30 |
Astrazeneca Ab |
2-(2,4,5-substitueret anilino)pyrimidinforbindelser
|
|
EP2832734A4
(en)
|
2012-03-28 |
2015-08-26 |
Takeda Pharmaceutical |
HETEROCYCLIC COMPOUND
|
|
WO2014155300A2
(en)
|
2013-03-28 |
2014-10-02 |
Aurigene Discovery Technologies Limited |
Substitued pyrimidine amine derivatives as tak-1 inhibitors
|
|
MX358346B
(es)
|
2014-04-04 |
2018-08-15 |
Syros Pharmaceuticals Inc |
Inhibidores de la quinasa dependiente de ciclina 7 (cdk7).
|
|
CA2949793C
(en)
|
2014-06-19 |
2024-02-27 |
Ariad Pharmaceuticals, Inc. |
Heteroaryl compounds for kinase inhibition
|
|
CN113121575A
(zh)
|
2014-08-25 |
2021-07-16 |
四川海思科制药有限公司 |
一种(取代的苯基)(取代的嘧啶)胺基衍生物及其制备方法和药物用途
|
|
CN111170998B
(zh)
|
2014-11-05 |
2023-04-11 |
益方生物科技(上海)股份有限公司 |
嘧啶或吡啶类化合物、其制备方法和医药用途
|
|
JP6564449B2
(ja)
|
2015-02-20 |
2019-08-21 |
第一三共株式会社 |
がんの併用治療法
|
|
WO2016155655A1
(zh)
|
2015-04-03 |
2016-10-06 |
上海瑛派药业有限公司 |
Parp抑制剂固体药物剂型及其应用
|
|
KR101799781B1
(ko)
|
2015-07-23 |
2017-11-22 |
재단법인 강릉과학산업진흥원 |
소뼈 추출분말의 제조방법
|
|
US10829484B2
(en)
|
2015-07-28 |
2020-11-10 |
Plexxikon Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
|
CN107531725B
(zh)
|
2015-08-13 |
2021-03-19 |
北京韩美药品有限公司 |
Irak4抑制剂及其应用
|
|
CA2998042C
(en)
|
2015-09-14 |
2022-07-05 |
Brunangelo Falini |
Dactinomycin compositions and methods for the treatment of acute myeloid leukemia
|
|
BR112018009463A8
(pt)
|
2015-11-11 |
2019-02-26 |
Celator Pharmaceuticals Inc |
ensaios e métodos para selecionar um regime de tratamento para um sujeito com leucemia
|
|
SG10201913290QA
(en)
|
2016-03-15 |
2020-03-30 |
Oryzon Genomics Sa |
Combinations of lsd1 inhibitors for the treatment of hematological malignancies
|
|
EP3436014A4
(en)
*
|
2016-03-29 |
2019-11-27 |
Astellas Pharma Inc. |
COMBINATION THERAPY FOR THE TREATMENT OF ACUTE MYELOIC LEUKEMIA
|
|
EP3478675B1
(en)
|
2016-06-30 |
2020-04-22 |
Janssen Pharmaceutica NV |
Heteroaromatic derivatives as nik inhibitors
|
|
PL3541387T3
(pl)
|
2016-11-15 |
2021-10-25 |
Novartis Ag |
Dawka i schemat dla inhibitorów interakcji hdm2-p53
|
|
MA47233A
(fr)
|
2016-12-19 |
2019-10-23 |
Epizyme Inc |
Composés hétérocycliques substitués par une amine utilisés comme inhibiteurs de l'ehmt2 et leurs méthodes d'utilisation
|
|
PE20191108A1
(es)
|
2017-01-17 |
2019-08-26 |
Astrazeneca Ab |
Inhibidores selectivos de jak1
|
|
KR102175710B1
(ko)
|
2017-01-23 |
2020-11-06 |
주식회사 엘지화학 |
폴리아릴렌 설파이드 수지 조성물
|
|
TWI810172B
(zh)
|
2017-01-26 |
2023-08-01 |
南韓商韓美藥品股份有限公司 |
嘧啶化合物及包括其的藥學組成物
|
|
KR20190128646A
(ko)
|
2017-02-21 |
2019-11-18 |
압토스 바이오사이언시스 인코포레이티드 |
혈액 종양 환자들의 치료 방법
|
|
WO2019025484A1
(en)
|
2017-08-01 |
2019-02-07 |
Julius-Maximilians-Universität Würzburg |
USE OF CAR-MODIFIED T LYMPHOCYTES FOR FLT3 AND FLT3 INHIBITORS FOR TREATING ACUTE MYELOID LEUKEMIA
|
|
CA3080197C
(en)
|
2017-10-27 |
2023-12-19 |
Plexxikon Inc. |
Formulations of a compound modulating kinases
|
|
DK3755703T3
(da)
|
2018-02-20 |
2022-06-27 |
Incyte Corp |
N-(phenyl)-2-(phenyl)pyrimidin-4-carboxamidderivater og relaterede forbindelser som hpk1-inhibitorer til behandling af kræft
|
|
PE20210642A1
(es)
|
2018-07-13 |
2021-03-23 |
Gilead Sciences Inc |
Inhibidores de pd-1/pd-l1
|
|
KR101954370B1
(ko)
*
|
2018-07-25 |
2019-03-05 |
한미약품 주식회사 |
피리미딘 화합물 및 이를 포함하는 암의 예방 또는 치료용 약학 조성물
|
|
KR102297587B1
(ko)
|
2018-08-07 |
2021-09-06 |
재단법인 대구경북첨단의료산업진흥재단 |
치환된 n-헤테로아릴 유도체, 이의 제조방법 및 이를 유효성분으로 포함하는 암의 예방 또는 치료용 약학적 조성물
|
|
CN113166110B
(zh)
|
2018-12-12 |
2023-08-11 |
暨南大学 |
2-氨基嘧啶类化合物及其应用
|
|
BR112021016522A2
(pt)
|
2019-02-22 |
2021-10-26 |
Hanmi Pharm. Co., Ltd. |
Composição farmacêutica para o tratamento da leucemia mieloide aguda
|
|
KR20200102948A
(ko)
|
2019-02-22 |
2020-09-01 |
한미약품 주식회사 |
Flt3 저해제 및 iap 길항제를 포함하는 급성 골수성 백혈병의 치료를 위한 약학적 조합물
|
|
EP3928780A4
(en)
|
2019-02-22 |
2022-12-07 |
Hanmi Pharm. Co., Ltd. |
PHARMACEUTICAL COMPOSITION CONTAINING A FLT3 INHIBITOR AND HYPOMETHYLATING AGENT FOR THE TREATMENT OF ACUTE MYELOIC LEUKEMIA
|
|
WO2020171649A1
(ko)
|
2019-02-22 |
2020-08-27 |
한미약품 주식회사 |
Flt3 저해제 및 iap 길항제를 포함하는 급성 골수성 백혈병의 치료를 위한 약학적 조합물
|
|
EP3991733A4
(en)
|
2019-06-27 |
2023-07-05 |
Hanmi Pharm. Co., Ltd. |
Pharmaceutical composition for treating acute myeloid leukemia, containing flt3 inhibitor and chemotherapeutic agents
|
|
WO2021066443A1
(ko)
|
2019-09-30 |
2021-04-08 |
한미약품 주식회사 |
Flt3 저해제 및 mdm2 저해제를 포함하는 급성 골수성 백혈병 치료용 약학적 조성물
|
|
WO2021159993A1
(en)
|
2020-02-14 |
2021-08-19 |
Pharmablock Sciences (Nanjing) , Inc. |
Inhibitors of interleukin-1 receptor associated kinase (irak) /fms-like receptor tyrosine kinase (flt3), pharmaceutical products thereof, and methods thereof
|
|
CN116583284A
(zh)
|
2020-11-05 |
2023-08-11 |
韩美药品株式会社 |
用于治疗髓性白血病的包括flt3抑制剂的药物组合物
|
|
KR20230056331A
(ko)
|
2021-10-20 |
2023-04-27 |
한미약품 주식회사 |
급성 골수성 백혈병의 치료를 위한 FLT3 저해제와 Bcl-2 저해제의 치료 유효적 조합
|
|
AU2023372170A1
(en)
|
2022-11-04 |
2025-04-24 |
Hanmi Pharm. Co., Ltd. |
Novel crystalline form of a pyrimidine compound and pharmaceutical compositions comprising the same and methods of use thereof
|
|
CN120857931A
(zh)
|
2022-12-10 |
2025-10-28 |
艾普托斯生物科学公司 |
用于治疗患有血液学恶性病的患者的方法
|
|
EP4719355A1
(en)
|
2023-05-31 |
2026-04-08 |
Hanmi Pharm. Co., Ltd. |
Solid dispersion of myeloid kinome inhibitors and pharmaceutical composition comprising the same
|